Considering the above-mentioned follow-uplimitations of the reported cases, only two patients (22%) with COVID-19-associated AVP-Dshowed reversibility of this pituitary dysfunction - one at 5 days and the other at 30 daysafter the AVP-D diagnosis (13,14). The gene discussed is AVP; the disease is COVID-19.